Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07534332) titled 'Disulfiram in Rheumatoid Arthritis' on April 9.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: University of Oklahoma
Condition:
Rheumatoid Arthritis
Inflammation
Obesity
Intervention:
Drug: Placebo
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: May 2026
Target Sample Size: 20
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07534332
Publ...